Killing Me Softly—Future Challenges in Apoptosis Research

by Mike-Andrew Westhoff, Oliver Brühl, Lisa Nonnenmacher, Georg Karpel-Massler, Klaus-Michael Debatin
Published 2014-03-01

Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.

by Mike-Andrew Westhoff, Najmeh Faham, Daniela Marx, Lisa Nonnenmacher, Claudia Jennewein, Stefanie Enzenmüller, Patrick Gonzalez, Simone Fulda, Klaus-Michael Debatin
Published 2013-01-01

Immune phenotypes predict survival in patients with glioblastoma multiforme

by Haouraa Mostafa, Andrej Pala, Josef Högel, Michal Hlavac, Elvira Dietrich, M. Andrew Westhoff, Lisa Nonnenmacher, Timo Burster, Michael Georgieff, C. Rainer Wirtz, E. Marion Schneider
Published 2016-09-01

A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy.

by Stephanie Ströbele, Matthias Schneider, Lukas Schneele, Markus D Siegelin, Lisa Nonnenmacher, Shaoxia Zhou, Georg Karpel-Massler, Mike-Andrew Westhoff, Marc-Eric Halatsch, Klaus-Michael Debatin
Published 2015-01-01